Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kaveri Pohlman is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/27/2024 | GMAB | Buy Now | Genmab | $27.64 | 70.04% | $46 → $47 | Maintains | Buy | Get Alert |
| 05/24/2024 | MGNX | Buy Now | Macrogenics | $4.93 | 82.56% | $24 → $9 | Maintains | Buy | Get Alert |
| 04/17/2024 | CGEM | Buy Now | Cullinan Oncology | $18.29 | 64.02% | $20 → $30 | Maintains | Buy | Get Alert |
| 04/16/2024 | XNCR | Buy Now | Xencor | $19.14 | 98.54% | $56 → $38 | Maintains | Buy | Get Alert |
| 03/26/2024 | NUVB | Buy Now | Nuvation Bio | $3.04 | 64.47% | → $5 | Upgrade | Neutral → Buy | Get Alert |
| 03/21/2024 | JANX | Buy Now | Janux Therapeutics | $44.68 | 38.76% | → $62 | Initiates | → Buy | Get Alert |
| 03/04/2024 | MGNX | Buy Now | Macrogenics | $4.93 | 386.82% | $12 → $24 | Maintains | Buy | Get Alert |
| 02/09/2024 | PYXS | Buy Now | Pyxis Oncology | $3.65 | 119.18% | → $8 | Initiates | → Buy | Get Alert |
| 12/19/2023 | EXEL | Buy Now | Exelixis | $22.60 | 19.47% | → $27 | Initiates | → Buy | Get Alert |
| 10/13/2023 | GMAB | Buy Now | Genmab | $27.64 | 66.43% | $44 → $46 | Maintains | Buy | Get Alert |
| 09/12/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $26 | Initiates | → Buy | Get Alert |
| 08/24/2023 | GMAB | Buy Now | Genmab | $27.64 | 59.19% | → $44 | Initiates | → Buy | Get Alert |
| 08/23/2023 | RCUS | Buy Now | Arcus Biosciences | $14.28 | 390.2% | → $70 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2023 | MGNX | Buy Now | Macrogenics | $4.93 | 143.41% | $6 → $12 | Maintains | Buy | Get Alert |
| 11/21/2022 | CGEM | Buy Now | Cullinan Oncology | $18.29 | 9.35% | → $20 | Initiates | → Buy | Get Alert |
| 11/14/2022 | ONCS | Buy Now | OncoSec Medical | — | — | — | Downgrade | Buy → Neutral | Get Alert |
| 08/31/2022 | STTK | Buy Now | Shattuck Labs | $4.62 | 159.74% | → $12 | Initiates | → Buy | Get Alert |
| 08/02/2022 | NUVB | Buy Now | Nuvation Bio | $3.04 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $1.37 | 483.9% | $16 → $8 | Maintains | Buy | Get Alert |
| 06/01/2022 | NEXI | Buy Now | NexImmune | $1.89 | 164.55% | → $125 | Initiates | → Buy | Get Alert |
| 04/20/2022 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | — | Downgrade | Buy → Neutral | Get Alert |
| 03/30/2022 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | $29 → $9 | Maintains | Buy | Get Alert |
| 03/16/2022 | ONCS | Buy Now | OncoSec Medical | — | — | $220 → $110 | Maintains | Buy | Get Alert |
| 02/24/2022 | ONCT | Buy Now | Oncternal Therapeutics | $7.00 | -28.57% | → $100 | Initiates | → Buy | Get Alert |
| 02/09/2022 | SONN | Buy Now | Sonnet BioTherapeutics | $0.88 | 127.35% | $1540 → $616 | Maintains | Buy | Get Alert |
| 11/15/2021 | CTMX | Buy Now | CytomX Therapeutics | $1.37 | 1067.8% | — | Initiates | → Buy | Get Alert |
